XDWS:F:F-Xtrackers MSCI World Consumer Staples UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 45.07

Change

-0.54 (-1.18)%

Market Cap

USD 0.73B

Volume

1.24K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.43%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.06 (-0.20%)

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.05 (-1.31%)

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.14 (+0.14%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.56%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

-0.07 (-0.91%)

USD 41.09B
0ZC:F Zscaler Inc

-0.22 (-0.14%)

USD 37.92B

ETFs Containing XDWS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.00% 73% C 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.00% 70% C- 60% D-
Trailing 12 Months  
Capital Gain 8.37% 48% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.37% 44% F 51% F
Trailing 5 Years  
Capital Gain 35.39% 61% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.39% 61% D- 51% F
Average Annual (5 Year Horizon)  
Capital Gain 6.64% 62% D 62% D
Dividend Return 6.64% 60% D- 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.99% 74% C 92% A
Risk Adjusted Return 83.08% 91% A- 92% A
Market Capitalization 0.73B 67% D+ 55% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike